COVID-19 vaccine hesitancy in Zambia (2)

1 May, 2022

This paper finds that only one-third of participants would accept the COVID-19 vaccine if made available to them.

CITATION: Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: a web-based cross-sectional study.

Pan African Medical Journal. 41 (no pagination), 2022. Article Number: 112. Date of Publication: Jan-Apr 2022.

Mudenda S. et al.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994469/

ABSTRACT

Introduction: vaccinations against COVID-19 have been instituted to contain the pandemic. However, information about the acceptability of COVID-19 vaccines in Zambia is lacking. Therefore, the study assessed the prevalence and factors associated with COVID-19 vaccine acceptance among the general population in Zambia.

Methods: this was an online questionnaire-based cross-sectional study conducted from 13th April to 21st May 2021. We included adult Zambians who had access to Facebook and WhatsApp. A multivariable logistic regression model was fitted to determine factors influencing vaccine acceptability. Data were analysed using Stata version 16.1.

Results: of the 677 participants, only 33.4% (n = 226) would accept the vaccine if made available to them. In multivariable regression analysis, respondents who were older than 41 years compared to the 18 to 23 years age group (aOR: 2.77, 95% CI: 1.03-7.48), those who agreed (aOR; 22.85, 95% CI: 11.49-45.49) or did not know (aOR; 3.73, 95% CI: 2.29-6.07) compared to those who disagreed that the COVID-19 vaccine passed through all the necessary stages to ensure its safety and effectiveness, and those who were aware (aOR; 11.13, 95% CI: 5.31-23.35) compared to those who were not aware that the COVID-19 vaccine reduces virus transmission, were more likely to accept the vaccine. Conversely, entrepreneurs compared to government employees (aOR; 0.24, 95% CI: 0.07-0.79) were less likely to accept vaccination.

Conclusion: awareness of the COVID-19 vaccine was high despite low acceptability levels. These findings are significant as they highlight the need to develop strategies for improving vaccine acceptability in Zambia.

Neil Pakenham-Walsh, Global Coordinator HIFA, www.hifa.org neil@hifa.org

Coordinator, HIFA project on COVID-19, supported by University of Edinburgh

https://www.hifa.org/projects/covid-19

Join HIFA: www.hifa.org/joinhifa

Join HIFA-Zambia: http://www.hifa.org/join/join-hifa-zambia